A research team has developed a new chemotherapeutic agent, LiPyDau, which shows remarkable efficacy against multiple tumor ...
Scientists uncover a molecular weakness that could transform prostate cancer therapy. An international team of researchers has identified a new weakness in prostate cancer cells that could enhance ...
In a promising advance for cancer treatment, Northwestern University scientists have re-engineered the molecular structure of ...
The U.S. Food and Drug Administration (FDA) has granted fast track designation to the antibody-drug conjugate JSKN003 for the ...
The experimental treatment, developed using cells at La Paz public hospital, achieves a preliminary survival rate of 70% in ...
An orchiectomy is a surgery that removes a testicle. Testes-sparing surgery is when a doctor removes the tumor and leaves the ...
(Reuters) -The U.S. Food and Drug Administration has approved British drugmaker GSK's blood cancer drug, Blenrep, in one ...
An exosome-based treatment of glioblastoma multiforme (GBM) has received orphan drug designation from the FDA. 1 Exousia AI, ...
The combination of Merck's Welireg and Eisai's Lenvima has not yet shown statistical significance in extending overall ...
Prior research on the potential role of cytokines found that IL-6 signaling can reprogram and alter T-cell immune responses ...
Mayo Clinic researchers have discovered a key reason why certain breast cancers might not respond to an important new class ...
Global Cancer Antibody Drug Conjugates Market Opportunity USD 70 Billion Opportunty By 2031 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback